Ratings by RBC Capital (Luca Issi)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/2/2026 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 3/2/2026 | Intellia Therapeutics | NTLA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/2/2026 | uniQure BV | QURE | Downgrade | Sector Perform (Outperform) |
15.63 (14.27) |
-8.7% | Details | |
| 2/27/2026 | argenx SE | ARGX | Maintain | (N/A) |
|
Details | ||
| 2/26/2026 | uniQure BV | QURE | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2026 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2026 | Beam Therapeutics Inc | BEAM | Maintain | (N/A) |
|
Details | ||
| 2/23/2026 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 2/17/2026 | Moderna | MRNA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/13/2026 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/4/2026 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 1/20/2026 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 1/20/2026 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 1/12/2026 | Moderna | MRNA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 1/12/2026 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 12/17/2025 | argenx SE | ARGX | Maintain | Outperform (N/A) |
|
Details | ||
| 12/17/2025 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 12/11/2025 | Arrowhead Pharma | ARWR | Maintain | Outperform (N/A) |
|
Details | ||
| 12/9/2025 | WAVE Life Sciences | WVE | Upgrade | Outperform (Sector Perform) |
7.49 (13.12) |
75.17% | Details | |
| 12/8/2025 | Fulcrum Therapeutics | FULC | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/21/2025 | Moderna | MRNA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/19/2025 | Arrowhead Pharma | ARWR | Maintain | Outperform (N/A) |
|
Details | ||
| 11/13/2025 | Korro Bio Inc. | KRRO | Downgrade | Sector Perform (Outperform) |
31.42 (11.18) |
-64.42% | Details | |
| 11/11/2025 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/7/2025 | Regenxbio Inc. | RGNX | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2025 | Intellia Therapeutics | NTLA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/6/2025 | Dyne Therapeutics | DYN | Maintain | (N/A) |
|
Details | ||
| 11/5/2025 | Ultragenyx Pharma | RARE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2025 | uniQure BV | QURE | Maintain | Outperform (N/A) |
|
Details | ||
| 10/31/2025 | argenx SE | ARGX | Maintain | Outperform (N/A) |
|
Details | ||
| 10/30/2025 | Ionis Pharmaceuticals | IONS | Maintain | (N/A) |
|
Details | ||
| 10/30/2025 | Ionis Pharmaceuticals | IONS | Maintain | (N/A) |
|
Details | ||
| 10/30/2025 | Fulcrum Therapeutics | FULC | Maintain | (N/A) |
|
Details | ||
| 10/30/2025 | Fulcrum Therapeutics | FULC | Maintain | (N/A) |
|
Details | ||
| 10/28/2025 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/28/2025 | Intellia Therapeutics | NTLA | Downgrade | Sector Perform (Outperform) |
25.60 (13.44) |
-47.5% | Details | |
| 10/28/2025 | Avidity Biosciences | RNA | Downgrade | Sector Perform (Outperform) |
49.15 (14.82) |
-69.85% | Details | |
| 10/8/2025 | uniQure BV | QURE | Maintain | Outperform (N/A) |
|
Details | ||
| 10/8/2025 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 10/8/2025 | Arrowhead Pharma | ARWR | Maintain | Outperform (N/A) |
|
Details | ||
| 9/29/2025 | argenx SE | ARGX | Maintain | Outperform (N/A) |
|
Details | ||
| 9/19/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 9/4/2025 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 8/25/2025 | argenx SE | ARGX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/25/2025 | argenx SE | ARGX | New Coverage | Outperform (N/A) |
663.73 (717.80) |
8.15% | Details | |
| 8/8/2025 | Regenxbio Inc. | RGNX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2025 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2025 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 8/8/2025 | Arrowhead Pharma | ARWR | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2025 | Amgen | AMGN | Maintain | Outperform (N/A) |
|
Details | ||
| 8/5/2025 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 7/29/2025 | Dyne Therapeutics | DYN | Maintain | Outperform (N/A) |
|
Details | ||
| 7/7/2025 | Regenxbio Inc. | RGNX | Maintain | Outperform (N/A) |
|
Details | ||
| 7/7/2025 | Korro Bio Inc. | KRRO | Maintain | Outperform (N/A) |
|
Details | ||
| 7/7/2025 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 7/7/2025 | Dyne Therapeutics | DYN | Maintain | Outperform (N/A) |
|
Details | ||
| 7/7/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 7/7/2025 | Allogene | ALLO | Maintain | Outperform (N/A) |
|
Details | ||
| 6/13/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 6/10/2025 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 5/30/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 5/13/2025 | Arrowhead Pharma | ARWR | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2025 | WAVE Life Sciences | WVE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/9/2025 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2025 | Dyne Therapeutics | DYN | Maintain | Outperform (N/A) |
|
Details | ||
| 5/9/2025 | Caribou Biosciences Inc. | CRBU | Maintain | Outperform (N/A) |
|
Details | ||
| 4/16/2025 | Ascendis Pharma | ASND | New Coverage | Outperform (N/A) |
155.50 (240.65) |
54.76% | Details | |
| 4/3/2025 | WAVE Life Sciences | WVE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/3/2025 | Regenxbio Inc. | RGNX | Maintain | Outperform (N/A) |
|
Details | ||
| 4/3/2025 | Moderna | MRNA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/3/2025 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 4/3/2025 | Dyne Therapeutics | DYN | Maintain | Outperform (N/A) |
|
Details | ||
| 4/3/2025 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 4/3/2025 | Beam Therapeutics Inc | BEAM | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/25/2025 | Lexeo Therapeutics | LXEO | Maintain | Outperform (N/A) |
|
Details | ||
| 3/24/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 3/11/2025 | Caribou Biosciences Inc. | CRBU | Maintain | Outperform (N/A) |
|
Details | ||
| 3/5/2025 | WAVE Life Sciences | WVE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/4/2025 | Verve Therapeutics | VERV | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2025 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2025 | Dyne Therapeutics | DYN | Maintain | Outperform (N/A) |
|
Details | ||
| 2/28/2025 | Avidity Biosciences | RNA | Maintain | Outperform (N/A) |
|
Details | ||
| 2/26/2025 | Beam Therapeutics Inc | BEAM | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/26/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/18/2025 | Moderna | MRNA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/12/2025 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/11/2025 | Arrowhead Pharma | ARWR | Maintain | Outperform (N/A) |
|
Details | ||
| 2/11/2025 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 1/8/2025 | Ultragenyx Pharma | RARE | Maintain | Outperform (N/A) |
|
Details | ||
| 1/7/2025 | bluebird bio | BLUE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 1/7/2025 | uniQure BV | QURE | Maintain | Outperform (N/A) |
|
Details | ||
| 1/7/2025 | Regenxbio Inc. | RGNX | Maintain | Outperform (N/A) |
|
Details | ||
| 1/7/2025 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 12/13/2024 | Editas Medicine | EDIT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 12/11/2024 | uniQure BV | QURE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/26/2024 | Avidity Biosciences | RNA | New Coverage | Outperform (N/A) |
43.25 (49.15) |
13.64% | Details | |
| 11/26/2024 | Dyne Therapeutics | DYN | New Coverage | Outperform (N/A) |
29.69 (14.86) |
-49.95% | Details | |
| 11/5/2024 | Adverum Biotechnologies | ADVM | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/4/2024 | Editas Medicine | EDIT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/21/2024 | WAVE Life Sciences | WVE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/21/2024 | Korro Bio Inc. | KRRO | Maintain | Outperform (N/A) |
|
Details | ||
| 9/26/2024 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 9/17/2024 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Sector Perform (N/A) |
|
Details | ||
| 9/13/2024 | Moderna | MRNA | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/26/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 8/14/2024 | Korro Bio Inc. | KRRO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/13/2024 | MeiraGTx Holdings plc | MGTX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/9/2024 | Verve Therapeutics | VERV | Maintain | Outperform (N/A) |
|
Details | ||
| 8/9/2024 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/6/2024 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/5/2024 | Moderna | MRNA | Downgrade | Sector Perform (Outperform) |
86.58 (52.52) |
-39.34% | Details | |
| 8/2/2024 | Moderna | MRNA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/2/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 7/19/2024 | Regenxbio Inc. | RGNX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/27/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 6/24/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 6/20/2024 | Regenxbio Inc. | RGNX | Maintain | Outperform (N/A) |
|
Details | ||
| 6/17/2024 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 6/12/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 6/10/2024 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 6/3/2024 | Moderna | MRNA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/30/2024 | Arrowhead Pharma | ARWR | Maintain | Outperform (N/A) |
|
Details | ||
| 5/3/2024 | Moderna | MRNA | Maintain | Outperform (N/A) |
|
Details | ||
| 4/22/2024 | Ultragenyx Pharma | RARE | New Coverage | Outperform (N/A) |
43.38 (21.25) |
-51.01% | Details | |
| 3/27/2024 | Korro Bio Inc. | KRRO | Maintain | Outperform (N/A) |
|
Details | ||
| 3/19/2024 | Adverum Biotechnologies | ADVM | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/12/2024 | Lexeo Therapeutics | LXEO | Maintain | Outperform (N/A) |
|
Details | ||
| 3/8/2024 | Regenxbio Inc. | RGNX | Upgrade | Outperform (Sector Perform) |
23.23 (8.65) |
-62.76% | Details | |
| 3/6/2024 | WAVE Life Sciences | WVE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/27/2024 | Beam Therapeutics Inc | BEAM | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/22/2024 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/12/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 1/26/2024 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 1/22/2024 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 12/11/2023 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/29/2023 | Korro Bio Inc. | KRRO | New Coverage | Outperform (N/A) |
39.92 (31.42) |
-21.29% | Details | |
| 11/28/2023 | Lexeo Therapeutics | LXEO | New Coverage | Outperform (N/A) |
11.30 (6.85) |
-39.38% | Details | |
| 11/10/2023 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2023 | uniQure BV | QURE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2023 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/3/2023 | Moderna | MRNA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2023 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2023 | Sangamo BioSciences | SGMO | Downgrade | Sector Perform (Outperform) |
0.59 (0.38) |
-35.59% | Details | |
| 10/11/2023 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2023 | MeiraGTx Holdings plc | MGTX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/9/2023 | Sangamo BioSciences | SGMO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/4/2023 | Moderna | MRNA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/1/2023 | uniQure BV | QURE | Maintain | Outperform (N/A) |
|
Details | ||
| 7/25/2023 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 5/12/2023 | MeiraGTx Holdings plc | MGTX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/11/2023 | Beam Therapeutics Inc | BEAM | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/8/2023 | Editas Medicine | EDIT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/4/2023 | Regenxbio Inc. | RGNX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/15/2023 | MeiraGTx Holdings plc | MGTX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/2/2023 | Moderna | MRNA | New Coverage | Sector Perform (N/A) |
138.81 (52.52) |
-62.16% | Details | |
| 2/9/2023 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 2/7/2023 | Arrowhead Pharma | ARWR | Maintain | Outperform (N/A) |
|
Details | ||
| 1/6/2023 | Graphite Bio Inc | GRPH | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/18/2022 | Editas Medicine | EDIT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/11/2022 | WAVE Life Sciences | WVE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/11/2022 | Homology Medicines | FIXX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/11/2022 | Adverum Biotechnologies | ADVM | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/8/2022 | Verve Therapeutics | VERV | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2022 | bluebird bio | BLUE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/7/2022 | Beam Therapeutics Inc | BEAM | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/4/2022 | Regenxbio Inc. | RGNX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/4/2022 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2022 | Editas Medicine | EDIT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/2/2022 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/4/2022 | Regenxbio Inc. | RGNX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 9/20/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 8/12/2022 | Adverum Biotechnologies | ADVM | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/5/2022 | bluebird bio | BLUE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/4/2022 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/4/2022 | Regenxbio Inc. | RGNX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/13/2022 | Caribou Biosciences Inc. | CRBU | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2022 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/3/2022 | Sangamo BioSciences | SGMO | Maintain | Outperform (N/A) |
|
Details | ||
| 5/3/2022 | Sangamo BioSciences | SGMO | Maintain | Outperform (N/A) |
|
Details | ||
| 2/22/2022 | Homology Medicines | FIXX | Downgrade | Sector Perform (Outperform) |
3.86 (0.93) |
-75.91% | Details | |
| 2/18/2022 | Graphite Bio Inc | GRPH | New Coverage | Sector Perform (N/A) |
11.02 (3.18) |
-71.14% | Details | |
| 2/18/2022 | Caribou Biosciences Inc. | CRBU | New Coverage | Outperform (N/A) |
11.37 (1.82) |
-83.99% | Details | |
| 2/18/2022 | Verve Therapeutics | VERV | New Coverage | Outperform (N/A) |
30.21 (11.13) |
-63.16% | Details | |
| 2/16/2022 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 12/14/2021 | Allogene | ALLO | Maintain | Outperform (N/A) |
|
Details | ||
| 12/8/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/22/2021 | Alnylam Pharmaceuticals | ALNY | Upgrade | Outperform (Sector Perform) |
178.98 (320.66) |
79.16% | Details | |
| 11/19/2021 | Dicerna Pharmaceuticals | DRNA | Downgrade | Sector Perform (Outperform) |
21.28 (38.22) |
79.61% | Details | |
| 11/8/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2021 | bluebird bio | BLUE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/11/2021 | Regenxbio Inc. | RGNX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/8/2021 | Allogene | ALLO | Maintain | Outperform (N/A) |
|
Details | ||
| 10/7/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 9/14/2021 | Regenxbio Inc. | RGNX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/10/2021 | bluebird bio | BLUE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/6/2021 | Dicerna Pharmaceuticals | DRNA | Maintain | Outperform (N/A) |
|
Details | ||
| 7/2/2021 | Arrowhead Pharma | ARWR | Maintain | Outperform (N/A) |
|
Details | ||
| 6/29/2021 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/4/2021 | Intellia Therapeutics | NTLA | New Coverage | Outperform (N/A) |
76.77 (25.60) |
-66.65% | Details | |
| 5/4/2021 | Beam Inc | BEAM | New Coverage | Sector Perform (N/A) |
82.00 (26.54) |
-67.63% | Details | |
| 5/4/2021 | Editas Medicine | EDIT | New Coverage | Sector Perform (N/A) |
37.01 (2.00) |
-94.6% | Details | |
| 5/4/2021 | Sangamo BioSciences | SGMO | New Coverage | Outperform (N/A) |
11.78 (0.38) |
-96.77% | Details | |
| 4/29/2021 | Adverum Biotechnologies | ADVM | Downgrade | Sector Perform (Outperform) |
10.16 (4.36) |
-57.09% | Details | |
| 4/20/2021 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/30/2021 | WAVE Life Sciences | WVE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/29/2021 | bluebird bio | BLUE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/23/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 3/23/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 1/28/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 1/20/2021 | Regenxbio Inc. | RGNX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/24/2020 | Arrowhead Pharma | ARWR | Maintain | Outperform (N/A) |
|
Details | ||
| 10/23/2020 | uniQure BV | QURE | New Coverage | Outperform (N/A) |
39.50 (15.63) |
-60.43% | Details | |
| 10/23/2020 | Allogene | ALLO | Maintain | Outperform (N/A) |
|
Details | ||
| 9/1/2020 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 6/16/2020 | Adverum Biotechnologies | ADVM | Maintain | Outperform (N/A) |
|
Details | ||
| 5/13/2020 | Regenxbio Inc. | RGNX | New Coverage | Sector Perform (N/A) |
41.38 (8.65) |
-79.1% | Details | |
| 5/13/2020 | Homology Medicines | FIXX | New Coverage | Outperform (N/A) |
13.49 (0.93) |
-93.11% | Details | |
| 5/13/2020 | Dicerna Pharmaceuticals | DRNA | New Coverage | Outperform (N/A) |
24.35 (38.22) |
56.96% | Details | |
| 5/13/2020 | Adverum Biotechnologies | ADVM | New Coverage | Outperform (N/A) |
19.80 (10.16) |
-48.69% | Details | |
| 5/13/2020 | bluebird bio | BLUE | New Coverage | Outperform (N/A) |
60.23 (4.97) |
-91.75% | Details | |
| 5/13/2020 | Arrowhead Research | ARWR | New Coverage | Outperform (N/A) |
36.30 (59.82) |
64.79% | Details | |
| 5/13/2020 | Ionis Pharmaceuticals | IONS | New Coverage | Outperform (N/A) |
56.18 (74.04) |
31.79% | Details | |
| 5/13/2020 | Alnylam Pharmaceuticals | ALNY | New Coverage | Sector Perform (N/A) |
142.43 (320.66) |
125.14% | Details | |
| 10/23/0003 | CRISPR Therapeutics | CRSP | New Coverage | Sector Perform (N/A) |
92.22 (56.50) |
-38.73% | Details | |
| 10/23/0003 | WAVE Life Sciences | WVE | New Coverage | Sector Perform (N/A) |
8.21 (7.49) |
-8.77% | Details |
